Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 28, 2015 12:22 AM ET

Healthcare Providers and Services

Company Overview of Castle Biosciences Incorporated

Company Overview

Castle Biosciences Incorporated develops and commercializes diagnostic and prognostic tests for cancers. It offers DecisionDx-Melanoma, a gene expression profile test to identify stage I and II patients at high risk of metastasis based on biological information from 31 genes within their tumor tissue; DecisionDx-UM test to measure the activity or gene expression of a set of 15 genes within an ocular melanoma tumor to identify the likelihood of metastasis; and DecisionDx-EC test, which analyzes the localization of three protein biomarkers in a patient’s tumor to classify the cancer as either responsive to or resistant to pre-surgical chemoradiotherapy. The company also provides DecisionDx-Mes...

820 South Friendswood Drive

Suite 201

Friendswood, TX 77546

United States

Founded in 2007





Key Executives for Castle Biosciences Incorporated

Founder, Chief Executive Officer, President and Director
Age: 53
Chief Financial Officer
Age: 53
Vice President of Operations
Chief Medical Officer
Director of Reimbursement
Compensation as of Fiscal Year 2015.

Castle Biosciences Incorporated Key Developments

Castle Biosciences, Inc. Announces Executive Appointments

Castle Biosciences Inc. announced the appointment of Federico A. Monzon, M.D., FCAP, to the newly created role of Chief Medical Officer. The company also announced the appointment of Greg Schafer to Executive Director of Managed Care. Dr. Monzon is a molecular pathologist with extensive experience translating novel genomic technologies into clinical molecular tests. Most recently, he served as Medical Director of Oncology and Medical Director of Latin America at Invitae Corporation. Mr. Schafer has a strong background in managed care, sales and marketing, most recently serving as Head of Managed Care at Invitae Corporation, where he developed reimbursement and claims appeal strategy and increased in-network contracted providers.

Castle Biosciences Incorporated Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:00 PM

Castle Biosciences Incorporated Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:00 PM. Venue: Westin Grand Central, New York, New York, United States. Speakers: Derek J. Maetzold, Founder, Chief Executive Officer, President and Director.

Castle Biosciences, Inc. Announces Appointment of Bonnie H. Anderson to Board of Directors

Castle Biosciences Inc. announced the appointment of Bonnie H. Anderson to its Board of Directors. Ms. Anderson is the cofounder of Veracyte, where she serves as president and chief executive officer. Ms. Anderson’s career spans nearly 30 years in the diagnostics and life sciences markets. She cofounded Veracyte in 2008, spearheaded its successful initial public offering in 2013 and has led its commercialization efforts to date. Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in various leadership roles at Beckman Coulter.

Similar Private Companies By Industry

Company Name Region
Geisinger-Lewistown Hospital United States
ProVerde Laboratories, Inc. United States
The Waverley Group Inc. United States
Ultrasource, Inc. United States
Cardinal Health 200, LLC United States

Recent Private Companies Transactions

Private Placement
July 15, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Castle Biosciences Incorporated, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at